2021 KUMC Virtual Multidisciplinary Oncology Review


 

Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bemarituzumab, Margetuximab, Rucaparib+Ramucirumab+/-Nivo

288 views
June 11, 2021
Comments 0
Login to view comments. Click here to Login